Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 14/20 | 0.67 |
| ▸ | CYP2D6 | P10635 | 13/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.52 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29211966 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL29211967 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL30931891 | 1.00 | CYP3A4 (0.67) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL30931882 | 0.86 | CYP3A4 (0.90) | CYP3A4CYP2D6 | |
| SCHEMBL22492959 | 0.86 | CYP3A4 (0.58) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL22492952 | 0.86 | CYP3A4 (0.58) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL22492941 | 0.86 | CYP3A4 (0.58) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL22492962 | 0.86 | CYP3A4 (0.58) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL22492946 | 0.86 | CYP3A4 (0.58) | CYP3A4CYP2D6ADORA2AADORA1ALDH1A1 | |
| SCHEMBL20644323 | 0.85 | CYP3A4 (0.90) | CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118388536-A | Novel nucleoside reverse transcriptase inhibitors for antiviral use | 深圳市塔吉瑞生物医药有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-109320553-B | Nucleoside reverse transcriptase inhibitors for antiviral use | 深圳市塔吉瑞生物医药有限公司 | 2024-05-14 | — | — | CN | disclosed |